Bradley Foster & Sargent Inc Anixa Biosciences Inc Transaction History
Bradley Foster & Sargent Inc
- $6.18 Billion
- Q2 2025
A detailed history of Bradley Foster & Sargent Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 20,263 shares of ANIX stock, worth $65,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,263Holding current value
$65,854% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.31MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.53 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.01 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2 Million0.01% of portfolio
-
Ubs Group Ag505KShares$1.64 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.2 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $99.7M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...